philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018

Published 6 years ago • 18 plays • Length 2:51

Download video MP4
Download video MP3

Similar videos

1:49

philip philip md, phd, frcp, on screening patients at high risk for pancreatic cancer
4:42

philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma
2:43

philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer
2:02

philip philip md, phd, frcp, provides opinion on ngs and brca gene testing in pancreatic cancer
2:19

philip philip, md, on the outcomes of the polo study and its importance to physicians
5:17

philip philip md, phd, frcp, discusses outcomes from the polo trial in pancreatic cancer
1:14

philip philip md, phd, frcp, on brca gene mutations & outcomes in pancreatic cancer
2:03

philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer
1:05:51

dr. ha hong, ph.d. - chief artificial intelligence officer, medtronic endoscopy
2:37

phkl international patient centre
48:48

philips healthcare at charing cross lunch symposium - hybrid suite
2:21

philip philip, md, on what we’ve learned about the duration of therapy in the adjuvant crc setting
0:51

philip philip, md on what is impressing him at asco 2016 in crc
2:39

philip philip, md, explains how physicians should test for brca in pancreatic cancer patients
2:08

philip philip, md, phd, frcp, regarding key unmet needs in pancreatic ductal adenocarcinoma
1:24

philip philip, md, shares his impression of the capcitabine data in biliary cancers
2:04

philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient
3:00

philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas
0:57

philip philip, md, provides thoughts on the role of parp inhibitors in advanced pancreatic cancer
2:17

philip philip, md, reflects on the impact of pegph20 in met pancreatic cancer
1:35

philip philip, md, on integrating immunotherapy into existing treatment regimens for crc patients
14:41

philipp geyer, ph.d. of omicera on high-throughput clinical proteomics and applications to covid-19

Clip.africa.com - Privacy-policy